Neovacs S.A. | Balance Sheet
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,018.00
5,625.20
6,087.30
3,954.20
5,149.20
-
Total Accounts Receivable
2,811.30
2,818.60
4,446.20
4,220.60
5,032.80
-
Inventories
342.50
214.60
72.50
148.60
-
-
Other Current Assets
162.40
140.70
253.80
271.00
371.50
-
Total Current Assets
7,334.30
8,799.20
10,859.90
8,594.30
10,553.50
-
Net Property, Plant & Equipment
94.90
73.20
51.50
132.80
207.10
-
Total Investments and Advances
227.80
173.30
234.20
204.00
215.70
-
Intangible Assets
11.30
8.60
6.70
5.00
4.50
-
Other Assets
-
-
99.40
397.60
688.50
-
Total Assets
7,668.30
9,054.20
11,251.70
9,333.60
11,669.10
-
ST Debt & Current Portion LT Debt
9.50
4.70
3.60
4.10
1,709.40
Accounts Payable
2,179.00
1,474.70
3,431.40
6,124.10
7,100.80
Income Tax Payable
31.40
16.70
182.80
141.50
-
Other Current Liabilities
685.90
516.00
567.30
734.70
1,059.40
Total Current Liabilities
2,905.80
2,012.10
4,185.10
7,004.40
9,869.50
Long-Term Debt
1,111.80
1,288.50
738.30
804.60
744.00
Provision for Risks & Charges
171.10
186.30
260.00
269.10
209.90
Total Liabilities
4,188.70
3,487.00
5,183.50
8,078.10
10,823.40
Common Equity (Total)
386.30
2,473.90
6,068.20
1,255.50
845.70
Total Shareholders' Equity
386.30
2,473.90
6,068.20
1,255.50
845.70
Total Equity
386.30
2,473.90
6,068.20
1,255.50
845.70
Liabilities & Shareholders' Equity
7,668.30
9,054.20
11,251.70
9,333.60
11,669.10
Non-Equity Reserves
3,093.30
3,093.30
-
-
-
About Neovacs
View Profile
